about
Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide-maltodextrin complex.Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin.New sustained release of zidovudine matrix tablets - cytotoxicity toward Caco-2 cells.Physicochemical investigation and in vivo activity of anti-malarial drugs co-loaded in Tween 80 niosomes.Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride.Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl.Investigation of formulation variables and excipient interaction on the production of niosomes.Vancomycin-eluting niosomes: a new approach to the inhibition of staphylococcal biofilm on abiotic surfaces.Preparation of a novel floating ring capsule-type dosage form for stomach specific deliveryMetformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization.Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain.An in vivo study of Hypericum perforatum in a niosomal topical drug delivery system.Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation.Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation.Formulation and evaluation of proniosomes containing lornoxicam.Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle.Development and characterization of niosomal gel for topical delivery of benzoyl peroxide.Development, physicochemical characterization, and antimicrobial evaluation of niosomal myrtle essential oil.Hydrophobically modified chitosan nanoliposomes for intestinal drug deliverySmart niosomes of temozolomide for enhancement of brain targetingIntranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluationFormulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancementNiosomes as Nanoparticular Drug Carriers: Fundamentals and Recent Applications
P2860
Q35844751-ACD494E7-31BA-4836-87D7-64B4521E797AQ37126399-71C6E031-1F86-4125-87AD-26B1CFF07852Q38760966-FA186621-E4FB-44D8-AB90-726C4B07DC21Q38855594-2ABD96AF-673C-46EB-96FC-E3454C761C80Q39375439-250A18B3-8A3E-4C63-B2CF-EC118848E88BQ40066220-DD98334D-0134-4F23-8040-1BC393D4B358Q40594007-05D7E54A-1D2F-42CF-8C45-89CFEEB1B163Q40653236-E6C1A0F7-4CC9-4AC0-A332-E56D4B50275AQ40713954-DF45341A-C0B7-46D4-804C-B3F43831CECCQ41880762-DCDE4EE3-E8A4-456B-BA19-FD7A5A42B3B9Q41885249-2191E5E7-5144-4DD7-BC1A-84ECA8345679Q42146534-C0285903-20B1-4A0B-851B-B594C437AAC2Q43009479-454A90FA-B6EB-41FE-9F33-1D8115223177Q44837755-69A5A879-C74E-400B-83C9-8A2BBC158D39Q45996413-25BFC0D4-C606-49E5-8911-0188736691A7Q46202238-5DF840FF-2CC7-4420-8626-FB0B4601195CQ46489252-0007414E-A30D-400A-8DD9-84D1BC388285Q48140213-9CA19EA7-5909-47F2-B117-49EA611DB716Q49687529-5FCD7151-78D9-47B2-8C3A-10C08518CBF2Q50781900-2145ECE1-EE8A-4396-9133-641DA1160CD6Q51080718-491ACE13-592F-42BD-8664-D7589A042412Q53089921-953E9E22-864D-45B3-B568-28946E1AD73FQ53450275-C76E2897-7709-42DD-AB72-FF76C1C15647Q53749395-D56C31BB-58A3-4752-8BBA-B95D355819ADQ54572745-653815FD-FEE0-432E-AD50-D7CB4959A70CQ55003463-2A626379-5423-48B2-AE6D-A2B557761BDBQ57491087-A5758C1D-2BDF-472A-B24B-7524AB10FBAAQ57815995-708A4A48-1EBF-48D7-BC03-7AB46B6833F9Q58605996-C55B6A8A-67DC-4877-925F-51C872F538FCQ59101364-99334AD1-0FEC-45F1-B17F-EA7F7BB07B6DQ59128542-B5E6B816-BE69-47B1-9811-57AA3717BB9C
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Formulation and optimization of Zidovudine niosomes.
@en
type
label
Formulation and optimization of Zidovudine niosomes.
@en
prefLabel
Formulation and optimization of Zidovudine niosomes.
@en
P2860
P1433
P1476
Formulation and optimization of Zidovudine niosomes.
@en
P2093
Kandasamy Ruckmani
Veintramuthu Sankar
P2860
P2888
P304
P356
10.1208/S12249-010-9480-2
P407
P577
2010-07-16T00:00:00Z
P5875
P6179
1049222642